Harare, Zimbabwe — May 5, 2026
HARARE, Zimbabwe – May 5, 2026 – The Africa Clinical Research Network (ACRN) has launched its first clinical trial with Oracle in Africa, which commenced in February 2026. The PROgnostic Testing to Enhance Clinical Triage of Pre-eclampsia in Africa (PROTECT-Africa) trial aims to define, validate, and evaluate the clinical performance of placental biomarkers using innovative point-of-care platforms. The study will predict the absence or occurrence of severe pre-eclampsia-related maternal and fetal outcomes among African women with hypertensive disorders of pregnancy.
This trial is being conducted in Zimbabwe, Rwanda, and Tanzania and aims to recruit 1,106 pregnant women. Pre-eclampsia, along with severe complications such as eclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, is a leading cause of maternal and fetal morbidity globally, particularly in resource-limited settings across Africa.
ACRN selected Oracle's clinical trial and safety applications to advance its region-led, patient-centric research initiatives, focused on delivering essential treatments to communities faster and more equitably. The comprehensive Oracle cloud platform, including Oracle Clinical One, Argus Safety, and analytics, can help ACRN automate workflows, manage critical data, and run more efficient trials with the goal of enhancing safety and expanding patient access to clinical research across Africa.
"Our mission at ACRN is to empower African researchers to lead and participate in clinical trials that directly address the health needs of our communities. Oracle's robust and integrated clinical trial and safety solutions will enable us to conduct studies with greater efficiency, transparency, and, most importantly, an unwavering focus on patient well-being." — Tariro Makadzange, Chief Executive Officer, Africa Clinical Research Network
Delivering new research and innovation across Africa
<3%
Less than three percent of global clinical trials are currently conducted in Africa. ACRN is building the pan-African infrastructure to change this.
14 Countries · 59 Network Sites
Senegal
The Gambia
Ghana
Nigeria
Kenya
Uganda
Ethiopia
Rwanda
Tanzania
Malawi
Botswana
South Africa
Zambia
Zimbabwe
"Our collaboration with the Africa Clinical Research Network is a significant step toward advancing modern, patient-centric research that can help accelerate scientific breakthroughs across Africa. Together, we are creating the digital framework to enable innovation and AI integration into clinical research across the continent. The organization's on-the-ground expertise and dedication, combined with our cloud-based clinical trial and safety solutions, create a meaningful opportunity to drive innovation throughout the region, help bridge the research gap between Africa and the rest of the world, and ultimately support better health outcomes for communities." — Seema Verma, Executive Vice President and General Manager, Oracle Health and Life Sciences
Learn more about the ACRN and Oracle collaboration in this video
Learn how customers like ACRN use Oracle's unified life sciences platform at oracle.com/lifesciences
About Africa Clinical Research Network
The Africa Clinical Research Network (ACRN) is an African-led organization building a high-quality, connected platform for the delivery of clinical trials across Africa. ACRN works with healthcare institutions, investigators, industry, and public sector partners to strengthen site readiness, workforce capability, regulatory coordination, and data-driven trial execution. Its mission is to expand access to research opportunities and accelerate the development of medicines and health innovations relevant to African populations. www.acrnhealth.com →About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements—empowering the life sciences industry to improve patient outcomes. www.oracle.com/lifesciences →About Oracle Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit www.oracle.com.
Trademarks: Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.
